1. Home
  2. MDWD vs LLAP Comparison

MDWD vs LLAP Comparison

Compare MDWD & LLAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • LLAP
  • Stock Information
  • Founded
  • MDWD 2000
  • LLAP 2013
  • Country
  • MDWD Israel
  • LLAP United States
  • Employees
  • MDWD N/A
  • LLAP N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • LLAP Military/Government/Technical
  • Sector
  • MDWD Health Care
  • LLAP Industrials
  • Exchange
  • MDWD Nasdaq
  • LLAP Nasdaq
  • Market Cap
  • MDWD 179.1M
  • LLAP 165.7M
  • IPO Year
  • MDWD 2014
  • LLAP N/A
  • Fundamental
  • Price
  • MDWD $16.84
  • LLAP $0.25
  • Analyst Decision
  • MDWD Strong Buy
  • LLAP Buy
  • Analyst Count
  • MDWD 1
  • LLAP 3
  • Target Price
  • MDWD $28.00
  • LLAP $2.58
  • AVG Volume (30 Days)
  • MDWD 63.5K
  • LLAP 9.0M
  • Earning Date
  • MDWD 08-14-2024
  • LLAP 08-12-2024
  • Dividend Yield
  • MDWD N/A
  • LLAP N/A
  • EPS Growth
  • MDWD N/A
  • LLAP N/A
  • EPS
  • MDWD N/A
  • LLAP N/A
  • Revenue
  • MDWD $20,141,000.00
  • LLAP $133,107,000.00
  • Revenue This Year
  • MDWD $30.16
  • LLAP $8.71
  • Revenue Next Year
  • MDWD $18.44
  • LLAP $34.59
  • P/E Ratio
  • MDWD N/A
  • LLAP N/A
  • Revenue Growth
  • MDWD N/A
  • LLAP 10.75
  • 52 Week Low
  • MDWD $7.45
  • LLAP $0.23
  • 52 Week High
  • MDWD $24.00
  • LLAP $1.62
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 42.14
  • LLAP 26.22
  • Support Level
  • MDWD $16.25
  • LLAP $0.24
  • Resistance Level
  • MDWD $17.48
  • LLAP $0.25
  • Average True Range (ATR)
  • MDWD 1.02
  • LLAP 0.01
  • MACD
  • MDWD -0.23
  • LLAP 0.02
  • Stochastic Oscillator
  • MDWD 13.72
  • LLAP 12.42

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About LLAP Terran Orbital Corporation

Terran Orbital Corp is a manufacturer of satellite products primarily serving the aerospace and defense industries. The company provide end-to-end satellite solutions by combining satellite design, production, launch planning, mission operations, and on-orbit support to meet the needs of our military, civil, and commercial customers. Geographically company operates in United States and Europe. Majority of the revenue is generated from United States.

Share on Social Networks: